First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid

Abstract

Our results suggest that levetiracetam may have favorable efficacy compared to valproic acid, whereas level of toxicity seems similar. Therefore, levetiracetam seems to be the preferred choice for first-line AED treatment in patients with glioma.